特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
950064

体外診断 (IVD) 検査の世界市場:第13版

The Worldwide Market for In Vitro Diagnostic Tests, 13th Edition

出版日: | 発行: Kalorama Information | ページ情報: 英文 1,900+ Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.56円
体外診断 (IVD) 検査の世界市場:第13版
出版日: 2020年08月31日
発行: Kalorama Information
ページ情報: 英文 1,900+ Pages
納期: 即日から翌営業日
担当者のコメント
IVDのゴールドスタンダード的レポートとして世界的に定評あるレポートです。診断業界の動きがますます活発化していることから、従来の2年毎更新から2019年度より毎年更新に変更されました。本エディションでは、当然ながらCOVID-19についての情報も多く盛り込んで、セグメント別の業界及び企業の動向などについて最新の情報をお届けするものとなっています。構成内容は目次タブをご覧ください。原本試読で内容を確認頂く事も可能です。試読ボタン、または既知の営業担当者あてにご依頼ください。
  • 全表示
  • 概要
  • 目次
概要

IVD (体外診断用医薬品) が、これほどまでに重要だったことはありません。がん・感染症の検査、移植の成功、医薬品の選択が、医療の価値を高め、転帰を改善してきました。現在、COVID-19のパンデミックにより、検査の重要性が非常に高まっています。

当レポートでは、IVD (体外診断用医薬品) 市場について調査分析し、市場の概要、市場に対するCOVID-19の影響、市場規模と予測、市場の見通し、主要企業などについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 イントロダクション

第3章 世界のIVD (体外診断用医薬品) 市場の概要

  • 背景
  • 世界の人口と高齢化
  • 疾病の負担を軽減
  • COVID-19(新型コロナウイルス感染症)
  • 新興市場
  • 世界のIVD市場規模と予測
  • COVID-19 2020への影響
  • 米国のIVD市場
  • 欧州のIVD市場:成長市場
  • 東欧:成長地域
  • 日本:成長への回帰
  • 中国:現在のIVD市場
  • インド:人口と機会
  • その他のアジア
  • ブラジル
  • メキシコ
  • ロシア連邦
  • カナダ
  • 新興市場
  • IVD市場機会:国別

第4章 企業・業界動向

  • イントロダクション
  • 国境なき先進医療
  • 中国のIVD企業のイニシアチブ
  • プログラムとイニシアチブ
  • 遺伝子編集
  • マイクロバイオーム
  • リキッドバイオプシー
  • IVDにおけるITとAI
  • 薬物乱用:IVDの影響
  • 臨床検査室のキックバックスキーム
  • 敗血症:170億米ドルの問題

第5章 ポイントオブケア (POC) 検査

  • 概要と動向
  • プロフェッショナルPOC
  • OTC自己検査
  • 妊娠/受胎検査
  • 大腸がんのスクリーニング
  • 脂質検査
  • POC感染症検査
  • COVID-19
  • COVID-19 POC市場
  • 糖尿病検査:血糖値モニタリング
  • 主要なPOC検査企業

第6章 コアラボ

  • コアラボの概要と動向
  • コネクティビティ
  • 化学検査の概要
  • 市場分析
  • 睡眠時無呼吸検査:コアラボソリューション?
  • 化学検査の商業的見通し

第7章 イムノアッセイ

  • 概要と動向
  • 市場分析
  • 成熟アッセイセグメント
  • 成熟イムノアッセイ
  • 増殖イムノアッセイ
  • POCの革新
  • イムノアッセイの商業的見通し

第8章 分子アッセイ

  • 概要
  • サンプル調整と品質管理
  • 先進の分子検査・技術
  • 主要企業
  • 市場分析
  • 分子検査の商業的見通し

第9章 血液学

  • 血液学の概要と動向
  • ラボベースの血液検査
  • 分散型血液検査
  • 市場分析:主要サプライヤー
  • 血液検査の商業的見通し

第10章 凝固

  • 凝固・免疫血液検査の概要と動向
  • 特別なトピック
  • COVID-19
  • 市場分析
  • ラボベースの検査
  • 主要サプライヤー:ラボシステム
  • 分散型凝固検査:専門的用途
  • 主要サプライヤー:POCシステム
  • 凝固検査の商業市場

第11章 微生物学・ウイルス学

  • 感染の実際の影響
  • 微生物の抗生物質耐性:臨床検査の役割
  • 従来の微生物学とその限界
  • 新しい微生物学:イノベーション
  • 新しい感染症の脅威
  • 微生物学企業の買収と提携
  • 市場分析
  • 市場分析:従来の微生物学ID/AST
  • 従来のID/AST
  • 市場分析:微生物学イムノアッセイ
  • TORCH
  • 市場分析:分子微生物学
  • 質量分析
  • 微生物学の将来見通し

第12章 血液バンキングサービス

  • 概要
  • 世界の血液の安全性
  • 血液型・グループ市場
  • 血液検査市場
  • 血液バンキング検査の商業的見通し

第13章 組織学・細胞学

  • 概要
  • 特別なトピック
  • 市場分析
  • 組織学・細胞学検査の商業的見通し

第14章 企業プロファイル:トップティア

  • ABBOTT DIAGNOSTICS
  • AGILENT TECHNOLOGIES
  • BECKMAN COULTER, INC. / DANAHER
  • BECTON, DICKINSON AND COMPANY (BD)
  • BIOMERIEUX INC.
  • BIO-RAD LABORATORIES, INC
  • BRUKER CORPORATION
  • CEPHEID / DANAHER
  • DANAHER CORPORATION
  • GRIFOLS S.A.
  • HOLOGIC, INC.
  • INSTRUMENTATION LABORATORY (IL) / WERFEN
  • LEICA BIOSYSTEMS/DANAHER
  • ORTHO CLINICAL DIAGNOSTICS (ORTHO)
  • PERKINELMER, INC. (PE)
  • QIAGEN
  • QUIDEL CORPORATION
  • RADIOMETER A/S / DANAHER
  • ROCHE DIAGNOSTICS
  • SYSMEX CORPORATION
  • THERMO FISHER SCIENTIFIC INC.
  • VENTANA MEDICAL SYSTEMS INC. / ROCHE TISSUE DIAGNOSTICS
  • WERFEN

第15章 企業プロファイル:セカンドティア

  • ARKRAY
  • BGI GENOMICS (FORMERLY BEIJING GENOME INSTITUTE)
  • DEXCOM
  • EXACT SCIENCES
  • FUJIREBIO DIAGNOSTICS, INC.
  • GENMARK DIAGNOSTICS
  • COVID-19
  • GUARDANT HEALTH
  • HORIBA
  • ILLUMINA
  • LABCORP, LABORATORY CORPORATION OF AMERICA
  • LUMINEX CORPORATION
  • MASIMO CORPORATION
  • MERIDIAN BIOSCIENCE, INC.
  • MINDRAY - SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
  • MYRIAD GENETICS, INC.
  • NIHON KOHDEN CORPORATION
  • NOVA BIOMEDICAL CORPORATION (NOVA)
  • PHILIPS (ROYAL PHILIPS)
  • QUEST DIAGNOSTICS
  • RANDOX LABORATORIES LTD.

第16章 企業プロファイル:血液バンク専門企業

  • BLOODSOURCE (VITALANT)
  • CERUS CORPORATION
  • HAEMOKINESIS PTY LTD
  • IMMUCOR
  • MICROTYPING CONCEPTS
  • QUOTIENT LIMITED
  • RELIANCE LIFE SCIENCES

第17章 企業プロファイル:コアラボ・その他の企業

第18章 企業プロファイル:CTC・リキッドバイオプシー検査プロバイダー

第19章 企業プロファイル:専門企業

第20章 企業プロファイル:血液学 (細胞分析) ・凝固専門企業

第21章 企業プロファイル:組織病理学専門企業

第22章 企業プロファイル:イムノアッセイ専門企業

第23章 IVD向けIT専門企業

第24章 企業プロファイル:微生物学専門企業

第25章 企業プロファイル:分子検査専門企業

第26章 企業プロファイル:POC検査専門企業

第27章 企業プロファイル:出生前検査サービスプロバイダー

第28章 企業プロファイル:品質管理・サンプル調整専門企業

第29章 検査サービスプロバイダー

目次
Product Code: 20-050

Never before has in vitro diagnostics been so crucial. Tests for cancer and infectious disease detection, transplant success, pharmaceutical selection have added healthcare value and improved outcomes. Genetic tests for rare diseases and prenatal assessment are increaslying utilized. And now, the COVID-19 pandemic has highlighted how important testing is in a way that could not be impagined.

But in vitro diagnostics represents a large market, with scores of significant competitors. Sorting out the marketplace can be difficult without a definitive guide. What is the market size for clinical chemistry, immunoassays, molecular tests, hematology tests and other test categories? Who's winning? Who's launched game-changing products? Now in its 13th edition, this Kalorama Information report, The Worldwide Market for In Vitro Diagnostic (IVD) Tests, is the most essential report on the IVD industry. For two decades, the 1,500-plus page report has provided reliable estimates and real-world forecasts for the in vitro diagnostics industry.

As part of its offering, this report includes:

  • COVID-19 Impact on Markets, and COVID-19 Test Markets
  • 1500 + Page Report Based on Vendor Reporting, Interviews, Vendor Activities
  • Authored by Veteran IVD Analysts with Industry Knowledge
  • 12 Detailed Market Chapters with 2020 Market Estimates
  • Where is IVD Heading? - Market Segment Projections to 2025
  • Regional Breakouts Including Country IVD Markets
  • Sections on China and The United States IVD Markets
  • Coverage of Growth Markets: Eastern Europe and the Middle East, and Southeast Asia
  • Superior Company Profiles of Top Tier Companies and Hundreds of Smaller Concerns
  • Industry-Standard Business Planning Tools

Coverage of Trends and Market Estimates for Essential IVD Segments:

  • Clinical Chemistry
  • Point-of-Care
  • Molecular
  • Infectious Disease
  • Hematology
  • Coagulation
  • Blood Banking
  • Microbiology, ID/AST
  • Microboilogy, Pathogen Detection
  • Immunoassays, All Types
  • Histology and More.

The Worldwide Market for In Vitro Diagnostic (IVD) Tests estimates the current in vitro diagnostics market size and forecasted market size to 2025 for defined segments of the IVD market and various sub-segments, including:

  • COVID Testing - Immunoassays and Molecular
  • Molecular Assays (Infectious Disease, Blood Screening, Inherited Diseases, Oncology, PGx, Tissue Typing, Prenatal)
  • Clinical Chemistry and "Core Lab" Markets
  • Point-of-Care Testing (POC) (Professional and Self-Testing
  • Glucose Testing
  • Substance Abuse Testing
  • Microbiology and Virology by Test Type (Immunoassays, ID/AST, Infectious Diseases - DNA; ID/AST: Panels and Reagents, automated; Panels and Reagents, manual; Blood Culture; Chromogenic Media; Rapid Micro; Supplies)
  • Blood Banking
  • Pap, ISH, IHC, HPV and Other Tissue-Based Tests
  • Infectious Disease Immunoassay Testing
  • Hematology
  • Cardiac Markers, Tumor Markers, Diabetes/hbA1c, Autoimmune, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs
  • Coagulation Tests
  • Direct-to-Consumer Testing

For each of the listed in vitro diagnostics market segments, 2019 in vitro diagnostics market size, 2025 projection and compound annual growth rate is provided, as well as significant in vitro diagnostic companies in the market and IVD manufacturers' product innovations. The market data is put into a context with real-world industry and medical practice trends.

The Worldwide Market for In Vitro Diagnostic Tests has been called "The Bible of the IVD Industry" by customers, which include top IVD firms. Using Kalorama Information's The Worldwide Market for In vitro Diagnostic (IVD) Tests, 13th Edition, ensures that your firm will have the perspective and data of others in the in vitro diagnostics industry, as well as of those who track and invest in the IVD industry.

Global Coverage for a Global Industry

The in vitro diagnostics market is a global one, and The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 13th Edition reflects the international scope of the in vitro diagnostics market size. In the healthcare market, IVD companies sell globally and think globally. Trends in one part of the world affect IVD manufacturers' product decisions and company financial performance in others. Thus, this is a global report, and the following regional and country overall IVD markets are included:

  • US
  • Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Netherlands
  • Turkey
  • Poland
  • Canada
  • China
  • Japan
  • Saudi Arabia
  • Brazil
  • Eastern Europe
  • Emerging Markets
  • Rest of World

The Worldwide Market for In Vitro Diagnostic Tests is a testament to the Kalorama methodology. It is the result of months of painstaking work by an experienced IVD industry analyst, who has tracked hundreds of in vitro diagnostic companies for developments, trends and financial results. This research is compiled along with the opinion, observations and insights of industry experts to produce an unparalleled vision of the in vitro diagnostics industry as it is in 2020.

Who's In The Market? Who's Winning?

The report concentrates over a thousand pages on detailed and tiered profiles of companies in the in vitro diagnostics market. The experience that Kalorama Information has in the in vitro diagnostic market is evident in its tiering and segmentation of companies. First tier, second-tier and specialist companies are profiled. Financial results, product launches, company history and strategic plans are analyzed in the profiles. Over 200 Profiles are included in the report.

TABLE OF CONTENTS

CHAPTER 1: EXECUTIVE SUMMARY

  • Figure 1-1: The Worldwide IVD Market, 2019, 2020 and 2025 ($billions)
  • SCOPE AND METHODOLOGY
    • Table 1-1: Exchange Rate Fluctuations, 2015-2019
  • SIZE AND GROWTH OF THE MARKET
    • Table 1-1: Global In Vitro Diagnostic Sales by Product Market, 2020-2025 ($ million) (Clinical Chemistry; Immunoassays- non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology (ID/AST); Microbiology (molecular); Microbiology - Mass Spectrometry; Radioimmunoassays; Coagulation (PT/INR); Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry) and COVID-19 Dx 2020
  • IVD MARKET HIGHLIGHTS
  • COMPETITIVE PICTURE IN IVD
  • WHAT TO WATCH LONG-TERM
    • COVID-19
    • China and New Emerging Markets
    • Liquid Biopsy: A Testing Ground for AI in Diagnostics?
      • Table 1-2: Selected AI/Liquid Biopsy Initiatives
    • CRISPR-Based Diagnostics and First FDA Authorization
    • Today Urgent Care, Tomorrow Micro-hospitals
    • Globalization, Climate Change
  • FINDING WHAT YOU ARE LOOKING FOR IN THE 13TH EDITION
    • Table 1-3: Finding What You Are Looking For in the 13th Edition

CHAPTER 2: INTRODUCTION

  • REPORT DESIGN AND CHANGES IN SEGMENTS
    • Reporting Changes for Segments from the 12th Edition
  • IVD LANDSCAPE
  • THE CHALLENGE OF PAMA
  • MARKET ANALYSIS OF IVD MARKET SEGMENTS
    • Table 2-1: Global In Vitro Diagnostic Sales by Product Market, 2020-2025 ($ million) (Clinical Chemistry; Immunoassays- non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology (ID/AST); Microbiology (molecular); Microbiology - Mass Spectrometry; Radioimmunoassays; Coagulation (PT/INR); Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry) and COVID-19 Dx 2020
    • Figure 2-1: Developed vs. Developing IVD Market Shares, 2019-2020 and projected 2025 (%)
  • TOP SUPPLIERS AND NICHE PLAYERS
    • Introduction
    • Overview of the Top Tier Companies
      • Table 2-2: Clinical Diagnostics Revenues of Selected Top IVD Companies, 2015-2019 ($ million, estimated)
    • Overview of Selected Second Tier Companies
      • Table 2-3: Revenues of Selected Niche Players, 2015-2019 ($ million, estimated)
  • THE IMPACT OF COVID FOR THE TOP TIER COMPANIES
    • Figure 2-2: Top Tier Market Distribution, 2019 and 2020, estimated (%)
  • IVD COMPANIES MERGERS & ACQUISITIONS
    • Table 2-4: Selected IVD Mergers and Acquisitions
  • DISTRIBUTION AGREEMENTS
    • Table 2-5: Selected Diagnostics Industry Distribution Agreements, 2016, 2017, 2018, 2019, first half 20
  • LICENSES AND COLLABORATION AGREEMENTS
    • Table 2-6: Selected IVD Partnerships/Collaborations/Licensing Agreements, 2016, 2017, 2018, 2019, first half 2020
  • TEST SERVICES
    • Table 2-7: Selected Test Services, Sales 2015-2019 ($ millions, estimated where applicable)
    • Table 2-8: Global Lab Market Segmentation, 2019 ($ billions)
    • Table 2-9: Revenues for a Selection of U.S.-based Reference Labs, 2015-2019 ($ million, estimated)
  • HISTORICAL IVD MARKET VS TODAY
    • In the Beginning to Now
      • Figure 2-2: Share of IVD Market by Segment, Percentage, 2000 and 2020 Compared (Clinical Chemistry, Hematology, Coagulation, Immunoassays, Microbiology (ID/AST), POC Diabetes, POC - Other,
    • Histology/Cytology, Molecular, Blood Banking [imm & typing], Others)
    • Future
  • POINT OF VIEW
  • COVID-19 IMPACT AND SUMMARY
  • COVID-19 Market
    • Table 2-10: COVID-19 Market Estimates by Segment (ID/AST, Molecular Dx, Rapid - POC, Other), 2020 ($ millions)
    • Figure 2-3: IVD COVID-19 Market, Distribution by Region (North America, Europe, Asia Pacific, RoW), 2020 %

CHAPTER 3: THE GLOBAL PICTURE FOR IN VITRO DIAGNOSTIC MARKETS

  • BACKGROUND
    • Simultaneous Threats: Chronic and Acute
    • Expected World IVD Market Developments
  • GLOBAL POPULATION AND AGING
    • Table 3-1: Elderly Support Ratio in Various Countries (Australia; Brazil; Canada; China; China, Hong Kong SAR; France; Germany; India; Italy; Japan; Mexico; Saudi Arabia; Singapore; South Africa; Spain; Turkey; United Kingdom; United States; World)
    • Workforce Reduction
      • Table 3-2: Age Under 15 and Over 65, by Continent (Africa, L. America/Caribbean, Asia, Oceania, N. America, Europe, World) 2020
    • Addressing the Aging Trend
  • SHIFTING DISEASE BURDENS
    • Table 3-3: Changing DALY ranking of Disease Threats (disability-adjusted life year) Worldwide (HIV/AIDS, Malaria, Lung Cancer, TB, Neonatal Preterm Birth, Asthma, Heart Disease, Depression, Stroke, Cerebral Hemorrhage, Low Back Pain, Alzheimer's, COPD)
    • Increase in Chronic Diseases
  • COVID-19
    • Table 3-4: Individual EUAs for Molecular Tests for SARS-CoV-2
    • Table 3-5: Authorized Molecular-Based Laboratory Deveoped Tests for Detection of Nucleic Acid from SARS-CoV-2
    • Table 3-6: Individual EUAs for Antigen Diagnostic Tests for SARS-CoV-2
    • Table 3-7: Individual EUAs for Serology Tests for SARS-CoV-2
    • Table 3-8: Individual EUAs For IVDs for Management of COVID-19 Patients
  • EMERGING AND EMERGED MARKETS
    • Table 3-9: Market Potential by Total Population, and Percent Urban 2020 (China, India, United States, Brazil, Russia, Mexico, Nigeria, Turkey, S. Korea, S. Africa, Vietnam, Poland, Saudi Arabia, Canada, Colombia, Ukraine, Egypt, Malaysia)
    • Emerging Nations and Health Insurance
  • SIZE AND FORECAST FOR THE GLOBAL IVD MARKET
    • Table 3-10: Global In Vitro Diagnostic Market; Major Country/Region Markets, 2020 and 2025 ($ millions) (United States, EU 15/W. Europe, Japan, China, Canada, India, Eastern Europe, Brazil, Colombia, Mexico, Saudi Arabia, Turkey, UAE, Malaysia, Russia, South Africa, South Korea, Australia, ROW)
    • Table 3-11: Global In Vitro Diagnostic Market; Regional Markets, 2020 and 2025 ($ millions) (North America, Europe, Asia Pacific, Latin America, ROW)
  • COVID-19 Impact for 2020
    • Table 3-12: Global In Vitro Diagnostic Market - YOY Growth 2019-2020
    • Table 3-13: Global In Vitro Diagnostic Market; Regional Markets, 2019-2020 YOY Growth (North America, Europe, Asia Pacific, Latin America, ROW)
    • Regional Reporting Differences with the 12th Edition
  • THE IVD MARKET IN THE UNITED STATES
    • Table 3-14: United States IVD Market by Segment, 2020 (%) (Clinical Chemistry, Microbiology ID/AST, Microbiology Molecular, POC Diabetes, POC Other, Immunoassay Infectious Disease, Immunoassay Other, Clinical Sequencing, Nucleic Acid Assays, Coagulation, Histology, Hematology, Blood Grouping, Others)
    • PAMA and Reimbursement Changes
    • LDT Oversight Update
    • Rare Disease Testing
    • Personalized Medicine and NGS
  • IVD MARKET IN EUROPE: GROWING MARKETS
    • Figure 3-1: Europe: Growth in Healthcare Expenditure by Country, Projections 2018-2025 (Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, United Kingdom)
    • Europe Industry Actions
      • Table 3-15: Western European IVD Market by Country, 2020 ($ millions, estimated) (Austria, Belgium, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland/Norway, UK)
    • EU Regulation
      • Table 3-16: IVD Market Per Capita, Europe, 2019 Estimates (Switzerland, Germany, Netherlands, Sweden, France, Slovenia, United Kingdom, Italy, Spain, Slovakia, Greece, Croatia, Lithuania, Czech Republic, Hungary, Poland, Romania, Serbia, Bulgaria, Russia, Ukraine)
    • Personalized Medicine in Europe
    • Brexit
  • EASTERN EUROPE: GROWTH REGION
    • Figure 3-2: Eastern Europe: Growth in Healthcare Expenditure by Country, Projections 2018-2025 (Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Slovak Republic, Slovenia)
    • Table 3-17: Eastern European IVD Market by Country, 2020 ($ millions) (Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, Slovenia, Ukraine)
    • Figure 3-3: Eastern Europe IVD Market by Country, 2020 ($ millions) (Bulgaria, Croatia, Czech Republic, Hungary, Poland, Romania, Slovakia, Slovenia, Ukraine)
  • JAPAN: RETURN TO GROWTH
    • Table 3-18: Japan IVD Market by Segment, 2020 (%) (Clinical Chemistry, Microbiology ID/AST, Microbiology Molecular, POC Diabetes, POC Other, Immunoassay Infectious Disease, Immunoassay Other, Coagulation, Histology, Hematology, Others)
  • CHINA: CURRENT IVD MARKET
    • Table 3-19: China IVD Market by Segment, 2020 (%) (Clinical Chemistry, Microbiology ID/AST, Microbiology Molecular, POC Diabetes, POC Other, Immunoassay Infectious Disease, Immunoassay Other, Coagulation, Histology, Hematology, Others)
    • Table 3-20: Total Midyear Population by Broad Age Group: China (million persons), 2010-2050
    • Clinical Laboratory Tests in China
      • Figure 3-4: Number of Visits and Admissions to Hospital Institutions in China Annually, 2015 (General Hospitals, Specialized Hospitals, Chinese Medical Hospitals, Community Health Service Centers, Health Centers [Urban and Township], Village Clinics, Others)
    • Private Laboratories
    • Distribution in China
  • INDIA: POPULATION AND OPPORTUNITY
    • Table 3-21: India IVD Market by Segment, 2020 (%) (Clinical Chemistry, Hematology, Coagulation; Microbiology; POC Diabetes; POC Other; Immunoassay; Histology; Others)
    • Labs in India
  • REST OF ASIA
    • Table 3-22: Asia Pacific IVD Market by Country, 2020 ($ millions) (Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam)
  • BRAZIL
    • Disease Trends
      • Table 3-23: Brazil IVD Market by Broad Segment, 2020 (%) (Clinical Chemistry, Microbiology, POC Diabetes, POC Other, Immunoassay, Histology, Others)
  • MEXICO
    • Table 3-24: Mexico IVD Market by Broad Segment, 2020 (%) (Clinical Chemistry, Microbiology, POC, Immunoassay, Histology, Others)
  • THE RUSSIAN FEDERATION
  • CANADA
  • EMERGING MARKETS
    • Saudi Arabia IVD Market
    • South Africa IVD Market
    • Turkey IVD Market
    • Colombia IVD Market
    • United Arab Emirates (UAE) IVD Market
    • South Korea IVD Market
    • Other Markets to Watch
  • IVD MARKET OPPORTUNITY BY COUNTRY
    • Table 3-25: IVD Market Opportunity by Country (2020 Market Rank, Country CAGR 2020-2025) (China, Philippines, Brazil, Israel, Malaysia, India, Mexico, Indonesia, Chile, Poland, Saudi Arabia, South Korea, Romania, Colombia, United Arab Emirates, Argentina, Hungary, Vietnam, Iraq, Peru, Japan, France, Turkey, Egypt, Singapore, Luxembourg, Croatia, Jordan, U.S., Germany, United Kingdom, Canada, Spain, Russia, Netherlands, Switzerland, Belgium, Sweden, Austria, Denmark, Ireland, Finland, Iran, Thailand, Venezuela, Italy, Australia, Portugal, Greece, Czech Republic, South Africa, Norway, Bulgaria, Slovakia, Slovenia)
    • Figure 3-5: IVD Market Opportunity by Country: Top 20 Markets (Country Market Value ($millions), Country CAGR 2020-2025) (United States, Japan, Germany, China, France, United Kingdom, Canada, Italy, Spain, Brazil, Australia, Russia, Netherlands, India, Switzerland, Turkey, Poland, Belgium, Sweden, Mexico)

CHAPTER 4: COMPANY AND INDUSTRY TRENDS

  • INTRODUCTION
  • Advanced Medicine Without Borders
    • Table 4-1: Key Emerging IVD Markets (Brazil, India, China, South Korea, Mexico, Turkey, Vietnam) 2016-2020 ($millions)
    • China IVD Market
  • IVD Company Initiatives in China
    • Table 4-2: Selected IVD Initiatives in China
    • Clinical Genetic Test Advances
    • Direct to Consumer Genetic Test Services
  • Programs and Initiatives
    • Table 4-3: Selected Genomic Test Innovations
    • Future Trends
  • GENE EDITING
    • Table 4-4: Selected Gene Editing / CRISPR Innovations
    • CRISPR as a Diagnostic Tool
    • Basic Research
    • Food Industry
    • Investor Interest
  • MICROBIOME
    • Table 4-5: Selected Microbiome Test Innovations
  • LIQUID BIOPSY
    • Table 4-6: Liquid Biopsy: Selected Liquid Biopsy Innovations
    • Quality Assurance for Liquid Biopsy
    • Product News in Liquid Biopsy
    • Market Cleared Products
    • RUO Liquid Biopsy
    • Liquid Biopsy Products in Development
    • Liquid Biopsy in Microbiology
    • Liquid Biopsy Companies in 2020
    • The Future for Liquid Biopsy
  • IVD INFORMATION TECHNOLOGY AND AI
    • AI in Clinical Practice
      • Table 4-7: Selected AI Market Cleared Tests
    • The Regulatory Pathway for AI
    • Product Initiatives
      • Table 4-8: Selected AI Product Initiatives in Development and Collaborations
    • IBM Watson Health
    • Future Trends in AI
  • SUBSTANCE ABUSE: IVD IMPLICATIONS
    • Table 4-9: Screening and Brief Interventions for Substance Abuse by Select Country, 2014 data
    • Opioid Epidemic
    • Biomarkers and Substance Abuse
    • Clinical Laboratory Testing for Drugs of Abuse
      • Table 4-10: Global Drug Abuse Statistics
    • Urine
    • Blood
    • Oral
    • Hair
      • Table 4-11: Selected Opioid Test FDA Approvals, 2015-2020
  • CLINICAL LABORATORY KICKBACK SCHEMES
  • SEPSIS: A 17 BILLION-DOLLAR PROBLEM

CHAPTER 5: POINT-OF-CARE TESTS

  • OVERVIEW AND TRENDS
  • PROFESSIONAL POC
    • Table 5-1 Professional POC Test Sales by Category, Worldwide 2020 -2025 ($million) (Glucose, Critical Care POC, Fertility, Infectious Diseases, Cardiac Markers, Cholesterol, Coagulation, HbA1c POC, Hematology, Fecal Occult Blood, Drugs of Abuse, Others)
    • Table 5-2: Selected Profession POC Test Innovations
  • OTC SELF TESTING
    • Table 5-3: POC Self-Test Sales by Category, Worldwide, 2020-2025($million) (Glucose, Self; Glucose, Continuous; Pregnancy; Coagulation; Fecal Occult Blood; Drugs of Abuse; H. pylori; HIV; Cholesterol; Urinalysis; Other [TSH, Allergy, Autoimmune, etc])
  • PREGNANCY/FERTILITY TESTS
    • Table 5-4: POC Pregnancy and Fertility Test Market Distribution by End User, 2020(%) (OTC, PRO)
    • Table 5-5: Pregnancy/Fertility POC Test Sales Distribution by Global Region, 2020 (United States, Europe, Japan, RoW)
  • COLON CANCER SCREENING
    • Table 5-6: Selected POC Colon Cancer Tests
    • Table 5-7: Colon Cancer POC Test Sales Distribution by Global Region, 2020 (United States, Europe, Japan, RoW)
  • LIPID TESTING
    • Table 5-8: Lipid POC Test Sales Distribution by Global Region, 2020(United States, Europe, Japan, RoW)
  • POC INFECTIOUS DISEASE TESTING
    • Table 5-9: Innovations in Molecular POC Infectious Disease Diagnostics
    • Products
    • HIV and Hepatitis Testing and Monitoring
    • Tuberculosis
    • Tropical and Neglected Diseases
    • Respiratory Diseases
    • Sepsis and Nosocomial Disease
    • Sexual Health
    • Lyme Disease
      • Table 5-10: Innovations in Molecular POC Infectious Disease Diagnostics
  • COVID-19
    • Market Size and Growth
      • Table 5-11: Infectious Disease POC Test Demand by Type, 2020 (Influenza, HIV, STD, Hepatitis, Malaria, c.difficile, E.Coli, H.pylori, Home Test/OTC, Others)
  • COVD-19 POC Market
    • Other Developments
      • Table 5-12: Infectious Disease POC Test Sales Distribution by Global Region, 2020 (United States, Europe, Japan, RoW)
  • DIABETES TESTING - BLOOD GLUCOSE MONITORING
    • Glucose Testing in Tight Economics
      • Table 5-13: Glucose POC Test Sales Distribution by Global Region, 2020 (United States, Europe, Japan, RoW)
      • Figure 5-1: POC Glucose Testing Market Growth by Category, 2020-2025 CAGR (%) (Glucose OTC; Glucose Professional; Glucose, continuous; HbA1c POC)
    • IT to Aid Diabetes Management
      • Table 5-14: Selected Apps and Glucose Management IT
    • Diabetes Market Analysis
      • Table 5-15: Global Diabetes Sales by Test Category, 2020-2025 (Glucose, OTC; Glucose, professional; Glucose, continuous; HbA1c, POC; TOTAL; HbA1c, Lab) ($ millions)
    • POC Glucose Competitors
      • Table 5-16: POC Test Revenues of Selected IVD Glucose Companies, 2019 ($ million, estimated)
    • Blood Glucose Self-Testing
      • Table 5-17: Selected Glucose Self-Test Meter Innovations
    • Noninvasive Testing Devices
      • Table 5-18: Selected Noninvasive Glucose Monitoring Devices
    • Continuous Self Testing en Route to the Artificial Pancreas
      • Table 5-19: Selected Continuous Blood Glucose System Developments
    • Blood Glucose Testing by Professionals
      • Table 5-20: Selected Innovations in Hospital-based Glucose Monitoring
    • Diabetes Testing - Glycated Hemoglobin
      • Table 5-21: Global HbA1c Test Sales Market and Distribution by Setting, 2020-2025 ($ millions) (HbA1c POC, HbA1c Lab)
      • Table 5-22: Selected POC HbA1c Devices
    • Genes and Other Markers of Diabetes
      • Table 5-23: Selected POC Diabetes Monitoring Tests
    • Drugs of Abuse Testing
      • Table 5-24: POC Drugs of Abuse Test Sales Distribution by Setting, 2020 (Employment Screening, Criminal Justice, Critical Care - Traditional POC)
      • Table 5-25: Drugs of Abuse Tests on the Market
  • THE MAJOR POC TEST PLAYERS
    • Table 5-26: POC Test Revenues of Selected IVD Companies (excluding glucose), 2019 ($ million, estimated)

CHAPTER 6: THE CORE LAB

  • CORE LAB OVERVIEW AND TRENDS
    • Table 6-1: Workstation Sales, 2020-2025 (General Chemistries, Immunoassays on workstations; $ millions)
    • Table 6-2: Workstation Sales (General Chemistries, Immunos on Workstations) of the Top Five Manufacturers, 2019 (% Share, estimated)
    • Table 6-3: Selected Analytes for the Core Lab
  • CONNECTIVITY
  • OVERVIEW OF CHEMISTRY TESTS
    • Lab Automation
    • Service Plans
  • MARKET ANALYSIS
    • Table 6-4: Global Clinical Chemistry Sales by Test Category, 2020-2025 ($millions) (General Chemistries, Blood Gases, Urinalysis)
    • Table 6-5: Global Clinical Chemistry Sales Distribution by Region, 2020 (North America, Europe, Asia Pacific, RoW)
    • Table 6-6: Major Clinical Chemistry Companies
    • Table 6-7: Selected Clinical Chemistry Innovations
    • Rapid Response Systems
      • Table 6-8: Selected Major Whole Blood Chemistry Analyzers
    • Critical Care Analysis
      • Table 6-9: Blood Gas, Electrolyte and Critical Care Instrument Market by End User, 2020 and 2025 (Lab-based, POC-based)
      • Table 6-10: Blood Gas, Electrolyte, and Critical Care Market Leaders, 2019 (percent distribution of total sales)
    • User Apps
      • Table 6-11: Selected Apps, Critical Care and Urinalysis IT Innovations
    • Urinalysis
      • Table 6-12: Urinalysis Market by End User, 2020 and 2025 (Lab-based, POC-based)
      • Table 6-13: Urinalysis Systems Market Leaders, 2019 (percent distribution of total sales)
      • Table 6-14: Selected Urinalysis Innovations
  • SLEEP APNEA TESTING: CORE LAB SOLUTION?
  • THE COMMERCIAL OUTLOOK FOR CHEMISTRY TESTS

CHAPTER 7: IMMUNOASSAYS

  • OVERVIEW AND TRENDS
    • Immunoassay Technology Continues to Evolve
      • Table 7-1: Selected Immunoassay Technologies
    • Mass Spectrometry
      • Table 7-2: Selected Innovation in Mass Spectrometry for Routine Analyses
    • Immunoassays in the Core Lab
      • Figure 7-1: Workstation (General Chemistries, Immunoassays on Workstations) Sales Growth, CAGR 2020-2025
      • Table 7-3: Selected Immunoassay Innovations on Core Lab Instruments
    • Radioimmunoassays
  • MARKET ANALYSIS
    • Leading Suppliers and Growth Potential
      • Table 7-4 Global Lab-based Immunoassay (excluding infectious disease and blood screening) Sales, by Analyte Type, 2020-2025 ($millions) (Cardiac Markers, Tumor Markers, Autoimmune, Diabetes/HbA1c, Allergy, Thyroid, Proteins, Anemia, Fertility, Therapeutic Drugs, Drugs of Abuse, Vitamin D, Total; w/o HbA1c)
      • Table 7-5: Global Immunoassay (excluding infectious disease and blood screening) Sales Distribution by Region, 2020 (%) (North America, Europe, Asia Pacific, RoW)
    • Quality Control
      • Table 7-6: IVD Quality Control Market (estimated), 2020 and 2025
      • Figure 7-2: IVD Quality Control Market by Type, 2020
      • Table 7-7: Selected Immunoassay Quality Control Products
    • Immunoassay Market Growth and Competitive Picture
      • Table 7-8: 2019 Revenue of Leading Lab-based Immunoassay Vendors (in millions $), Estimated
  • MATURE ASSAY SEGMENT
    • Thyroid Function
    • Therapeutic Drug Monitoring
    • Anemia
    • Toxicology/DAU
    • Allergy
  • MATURING IMMUNOASSAYS
    • Proteins
  • GROWTH IMMUNOASSAYS
    • Vitamin D
      • Table 7-9: Selected Vitamin D Immunoassays
    • Tumor Markers
      • Table 7-10: Selected Tumor Marker Innovations
    • Cardiac Markers
      • Table 7-11: Selected Cardiac Marker Innovations
    • Autoimmune
      • Table 7-12: Selected Autoimmune Test Innovations
    • Rheumatoid Arthritis
      • Table 7-13: Selected Arthritis Immunoassay Innovations
    • Gastrointestinal Disorders
      • Table 7-14: Selected Inflammatory Bowel Disease Test Innovations
    • Transplant Management
      • Table 7-15: Selected Immunoassays for Transplant Medicine
    • Women's Health
      • Table 7-16: Selected Women's Health Innovations
    • Alzheimer's Disease
      • Table 7-17: Selected Innovations for Alzheimer's Disease Immunoassays
    • Sleep Apnea
    • Miscellaneous
      • Table 7-18: Selected Immunoassay Innovations
    • Point-of-Care OTC and Professional Use
      • Table 7-19: Global POC Immunoassay Sales Distribution by Region, 2020 (United States, Europe, Japan, RoW)
      • Table 7-20: Global POC Immunoassay Test Sales by Test Category, 2020-2025 (millions $) (OTC/Self Tests: Pregnancy/Ovulation, Drugs of Abuse, HIV, H. pylori, Other, OTC/Self Total; Professional POC: Cardiac Markers, Drugs of Abuse, HbA1c, Pregnancy, Other, Professional Total)
      • Table 7-21: Selected Self-Test Immunoassay Innovations
    • Pregnancy Testing
    • Cardiovascular Diagnostics
    • Drugs of Abuse/Therapeutic Drug Monitoring
  • INNOVATING POC
    • Table 7-22: Selected POC Test Innovations
    • Table 7-23: Selected POC Immunoassay Test Platforms
  • THE COMMERCIAL OUTLOOK FOR IMMUNOASSAYS

CHAPTER E8: MOLECULAR ASSAYS

  • OVERVIEW
    • Table 8-1: Common Next Generation Molecular Test Traits
  • SAMPLE PREPARATION AND QUALITY CONTROL
    • Table 8-2: Selected Molecular Test Sample Preparation and QC Innovations
  • ADVANCED MOLECULAR TESTS AND TECHNOLOGIES
    • Exosome Sequencing
      • Table 8-3: Selected Exosome Test Innovations
    • Liquid Biopsy
      • Table 8-4: Selected Liquid Biopsy Innovations
    • Metabolomic Profiling
    • Information Technology for Test Value
      • Table 8-5: Selected IT Innovations in Molecular Diagnostics
    • Artificial Intelligence AI
    • Forensic Studies - An Emerging Opportunity
      • Table 8-6: Selected Innovations in Forensic DNA Testing
    • Test Platforms
      • Table 8-7: Key Molecular Technologies and Major Players
      • Table 8-8: Selected Molecular Test Platform Innovations
  • MAJOR PLAYERS
    • Table 8-9: Molecular Test Revenues of Selected IVD Vendors, 2016-2019 (in millions $)
  • MARKET ANALYSIS
    • Table 8-10: Global Molecular Test Sales by Type 2020-2025 (in millions $) (Oncology, Transplant Testing, Thrombophilia SNPs, Pharmacodiagnostics, Inherited Diseases)
    • Oncology
      • Table 8-11: Global Molecular Cancer Test Sales Distribution by Region, 2020 (North America, Europe, Asia Pacific, RoW)
    • Pharmacodiagnostics
      • Table 8-12: Global Pharmacodiagnostic Sales Distribution by Region, 2020 (North America, Europe, Asia Pacific, RoW)
      • Table 8-13: Selected Molecular Tumor Marker Test Innovations
    • Inherited Diseases and Thrombophilia SNPs
      • Table 8-14: Most Frequently Requested Genetic Tests
      • Table 8-15: Global Molecular Thrombophilia Assay Sales Distribution by Region, 2020 (North America, Europe, Asia Pacific, RoW)
      • Table 8-16: Selected Genomic Tests for Inherited Diseases
    • Psychiatric Disorders
    • Prenatal and Newborn Testing
      • Table 8-17: Global Prenatal Test Sales Distribution by Region, 2020 (North America, Europe, Asia Pacific, RoW)
      • Table 8-18: Prenatal Services Provided
      • Table 8-19: Selected Molecular Tests for Prenatal Analysis
    • Tissue Typing
      • Table 8-20: Global Molecular HLA Testing Sales Distribution by Region, 2020 (North America, Europe, Asia Pacific, RoW)
      • Table 8-21: Selected HLA Typing Test Innovations
  • THE COMMERCIAL OUTLOOK FOR MOLECULAR TESTS
    • Table 8-22: IVD Quality Control Market (estimated), 2020 and 2025
    • Figure 8-1: IVD Quality Control Market by Type, 2020

CHAPTER 9: HEMATOLOGY

  • OVERVIEW OF HEMATOLOGY AND TRENDS
    • Table 9-1: Hematology Analyzer Distribution of Sales by Menu Capability, 2019 estimated
    • Table 9-2: Lab-based Hematology Sales by Analyte, 2019 estimated
    • Digital Image Analysis
      • Table 9-3: CellaVision Market Share Data by Hematology Vendor 2019
      • Table 9-4: Selected Hematology Image Analysis Innovations, 2014-2020
    • Digital Evolution
    • Quality Control Measurement Programs
      • Table 9-5: Quality Control Hematology FDA Registrations, 2020
  • LABORATORY-BASED HEMATOLOGY TESTING
    • Table 9-6: Selected Hematology Innovations, 2014-2019
    • Table 9-7: FDA Registration Distribution by Company for Hematology Analyzers/Instruments
    • Table 9-8: Global Laboratory-based Hematology Test and Instrument Market, 2020 and 2025 ($ millions)
    • Regional Laboratory-based Hematology Test and Instrument Market
      • Table 9-9: Global Laboratory-based Hematology Test and Instrument Market, by Region, 2020 (North America, Europe, Asia Pacific, RoW)
  • DECENTRALIZED HEMATOLOGY TESTING
    • Table 9-10: POC-based Hematology Analyzer/Instrument FDA Approvals by Year, through 2020
    • Hemoglobin/Hematocrit at the POC
      • Table 9-11: POC Hematology Distribution by Specialty (hematocrit/hemoglobin vs. other routine hematology (WBC, erythrocyte, platelet)
      • Table 9-12: Selected POC Hemoglobin and Hematocrit Systems
      • Table 9-13: Selected POC Hematology Analyzer Systems
      • Table 9-14: FDA Registration Distribution by Company for CLIA Waived Hematology Devices
      • Table 9-15: Decentralized Hematology Test and Instrument Market, 2020 and 2025 ($ millions) (Instruments, lab-style; Handheld devices)
  • MARKET ANALYSIS: LEADING SUPPLIERS
    • Table 9-16: Top Hematology Company Revenues (laboratory and POC), 2019 ($ millions)
    • Table 9-17: Global Hematology (Laboratory-based and POC) Sales Distribution by Region, 2020 (North America, Europe, Asia Pacific, RoW)
  • THE COMMERCIAL OUTLOOK FOR HEMATOLOGY TESTS

CHAPTER 10: COAGULATION

  • OVERVIEW AND TRENDS OF COAGULATION AND IMMUNOHEMATOLOGY TESTS
  • SPECIAL TOPICS
  • COVID-19
    • Direct Oral Anticoagulants (DOACs)
      • Table 10-1: Major Anticoagulants
    • D-dimer
      • Table 10-2: Global D-dimer Sales Distribution by Region, 2019 (North America, Europe, Asia Pacific, RoW)
  • MARKET ANALYSIS
    • Table 10-3: Global Coagulation Sales by Segment, 2020-2025 ($millions) (PT/INR Labs, Molecular, Professional POC, Professional Self; D-dimer)
    • Table 10-4: Global Coagulation Test and Instrument Market by Region, 2020 (North America, Europe, Asia Pacific, RoW)
  • LAB-BASED TESTING
    • Table 10-5: Selected Lab-based Coagulation Innovations
    • Genetic Markers of Hypercoagulopathies
      • Table 10-6: Related CMS Codes for Reimbursement National Limits, Molecular, 2020
      • Table 10-7: Global Molecular - Thrombophilia SNP Sales Distribution by Region, 2020 (North America, Europe, Asia Pacific, RoW)
      • Table 10-8: Selected Molecular Coagulation Test Innovations
  • LEADING SUPPLIERS: LABORATORY SYSTEMS
    • Table 10-9: Top Coagulation Company Revenues, Laboratory-based - 2019 ($ millions)
  • DECENTRALIZED COAGULATION TESTING - PROFESSIONAL USE
    • Decentralized Coagulation Testing - OTC
      • Table 10-10: Selected POC Coagulation Test Innovations
    • Platelet Testing
      • Table 10-11: Selected Platelet Activity Test Innovations
  • LEADING SUPPLIERS: POC SYSTEMS
    • Table 10-12: Top Coagulation Company Revenues, POC - 2019 ($ millions)
  • THE COMMERCIAL MARKET FOR COAGULATION TESTS
    • Table 10-13: Major Anticoagulants Uses and Tests

CHAPTER 11: MICROBIOLOGY AND VIROLOGY

  • THE REAL IMPACT OF INFECTIONS
    • Herpes and Alzheimer's Disease
    • Ebola and Cancer
    • HIV and Cancer
    • H pylori and Cancer
    • Bacteria and Parkinson's
  • MICROBIAL ANTIBIOTIC RESISTANCE - THE ROLE OF CLINICAL TESTS
    • "Faster Identification: Where Are We?"
      • Table 11-1: Selected Companies Developing Faster Identification, Some Also with Antimicrobial Susceptibility/Resistance Tests
  • TRADITIONAL MICROBIOLOGY AND ITS LIMITS
  • THE NEW MICROBIOLOGY - INNOVATIONS
    • Liquid Based Microbiology and Automation Innovations
    • Post-Blood Culture Microbial ID
    • PCR and Other NAAT-Based Tests for Infectious Diseases
      • Table 11-2: Selected Nucleic Acid Amplification Tests and Other Molecular Companies in Microbiology
    • Microbiome-Related Microbiology Tests
      • Table 11-3: Selected Microbiome-Based Tests
    • Next Generation Sequencing-Based Microbiology Approaches
      • Table 11-4: Selected Companies Applying DNA/RNA Sequencing to Microbiology
    • Syndromic Testing
  • NEW INFECTIOUS DISEASE THREATS
    • Table 11-5: Selected Companies Marketing Products Addressing Emerging Infectious Disease Threats
    • Tickborne Diseases (TBDs)
    • Zika
    • Chagas
    • Dengue
    • Ebola
    • Chikungunya
    • Next Threats?
      • Table 11-6: Country COVID-19 Test Volume, Average per Day (July-August 2020)
      • Figure 11-1: Total COVID-19 Test Volume by Country, Estimated 2020 (Millions)
      • Figure 11-2: Estimated Market Distribution, COVID-19 Test Value, 2020
  • MICROBIOLOGY FIRMS ACQUISITIONS AND COLLABORATIONS
  • MARKET ANALYSIS
    • Table 11-7: Global Microbiology Sales Distribution by Region, 2020 (North America, Europe, Asia Pacific, RoW)
  • MARKET ANALYSIS - TRADITIONAL MICROBIOLOGY ID/AST
    • Table 11-8: Global Microbiology ID/AST Market, 2020-2025 (in millions USD) (ID/AST Auto, ID/AST Panels, Blood Culture, Chromogenic Media, Rapid Microbiology; ID/AST Supplies)
    • Table 11-9: Global ID/AST Testing Sales Distribution by Region, 2020 (North America, Europe, Asia Pacific, RoW)
  • Traditional ID/AST
    • Table 11-10: Global ID/AST Testing, Distribution by Systems, 2020 (%) (Panel, Auto)
    • Blood Culture
      • Table 11-11: Selected Advanced Techniques in Positive Blood Culture
    • Chromogenic Media
    • Rapid Tests Performed on Colonies from Culture Media
    • Supplies
  • MARKET ANALYSIS - MICROBIOLOGY IMMUNOASSAYS
    • Improvements in Microbiology Immunoassays
      • Table 11-12: Selected Infectious Disease Immunoassay Innovations
      • Table 11-13: Global Clinical Laboratory-Based Microbiology/Infectious Disease Immunoassay Market by Pathogen, 2020 (in $ millions) (Hepatitis, HIV, STDs, TORCH, Respiratory, HAIs/Sepsis, Parasitology, Mycology, Lyme disease, Other)
      • Table 11-14: Global Laboratory-Based Microbiology/Infectious Disease Immunoassay Market Distribution (by %) by Region, 2020 (North America, Europe, Asia Pacific, RoW)
    • Hepatitis Testing
    • Sepsis
    • HIV Immunoassay Testing
      • Table 11-15: Selected HIV Assays
    • Sexually Transmitted Diseases (STDs)
  • TORCH
    • Lyme Disease
    • Rapid Immunoassay Tests
      • Table 11-16: Global Rapid Immunoassay Testing Market, Sales Distribution by Pathogen, 2020 (%) (Influenza, HIV, STD, Hepatitis, Malaria, c.difficile, E.Coli, H.pylori, Home Test/OTC, Others)
  • MARKET ANALYSIS - MOLECULAR MICROBIOLOGY
    • Table 11-17: Global Molecular Microbiology Sales Distribution by Region, 2020 (%) (North America, Europe, Asia Pacific, RoW)
    • Table 11-18: Global Molecular Microbiology Market, by Pathogen/Disease Indication, 2020-2025 (in $ millions) (HAI, HIV, Hepatitis, GC/Chlamydia, Respiratory, Organism ID, Mycobacteria/TB, Others; Blood Bank Screening)
    • Molecular Respiratory Infection Testing
    • The Respiratory Trio - Flu, Strep, RSV
      • Table 11-19: Selected Molecular Point of Care Innovations in Microbiology
    • Molecular Testing for Sexually Transmitted Diseases
    • Molecular Hepatitis Testing
    • Molecular HIV Testing
      • Table 11-20: Innovations in Molecular POC Diagnostics for HIV
    • Molecular Tests for Hospital-Acquired Infections (HAIs)
      • Table 11-21: Frequency of the Most Common Nosocomial Infections
    • Assessing the Problem: Nosocomial Infection Statistics
    • Clostridium Difficile
    • MRSA
    • Molecular TB Testing
    • Limitations of Molecular Microbiology Testing
  • MASS SPECTROMETRY
    • Table 11-22: Selected Companies Marketing Mass Spectrometers and/or Assays for the Clinical Laboratory [CE-Marked and/or 510(k) cleared]
  • THE FUTURE OUTLOOK FOR MICROBIOLOGY

CHAPTER 12: BLOOD BANKING SERVICES

  • OVERVIEW
    • Table 12-1: History of Blood Testing
    • The Current Status of Global Blood Collection
  • GLOBAL BLOOD SAFETY
    • Table 12-2: Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries (Syphilis, HCV, HBV, HIV, Chagas, Malaria, HTLV I/II)
    • Table 12-3: Prevalence of TTIs in Blood Donations [Median (Interquartile range)], by Income Group
    • Zika Virus
    • Blood and Component Collection
      • Table 12-4: Blood Component Usage for Selected Conditions
      • Table 12-5: Red Blood Cell and Platelet Use by Hospital Services (%)
    • COVID-19 Impact on Plasma Collection
    • Reevaluating Blood Transfusions
      • Table 12-6: Impact of Alloimmunization (% of Patients Screening Positive for One or More Antibodies)
  • BLOOD TYPING AND GROUPING MARKET
    • Manual Blood Typing Methods
    • Automated Blood Typing and Screening Methods
    • Molecular Methods
    • Reducing Blood Typing Errors
      • Table 12-7: Selected Blood Typing and Grouping Innovations
    • Size and Growth of Typing Markets
      • Table 12-8: Global Blood Typing Market, 2020-2025 (Typing) (in $ millions)
    • Blood Typing Market by Geography
      • Table 12-9: Global Blood Typing Sales Distribution by Region, 2020 (%) (North America, Europe, Asia Pacific, RoW)
  • BLOOD TESTING MARKET
    • Table 12-10: Selected Blood Testing Innovations
    • Preventing Bacterial Infections
    • Immunoassays
    • Nucleic Acid Testing (NAT)
    • Size and Growth of the Market
      • Table 12-11 Global Blood Banking Diagnostics Market, 2020-2025 (Immunoassay Screen, NAT Screens) (in $ millions)
    • Blood Testing Market by Geography
      • Table 12-12: Global Blood Testing Market by Geography, 2020 (%) (North America, Europe, Asia Pacific, RoW)
      • Table 12-13: Global Blood Testing Market by Country, 2020 (%) (United States, Canada, Germany, United Kingdom, France, Japan, China, Latin America)
  • THE COMMERCIAL OUTLOOK FOR BLOOD BANKING TESTING

CHAPTER 13: HISTOLOGY AND CYTOLOGY

  • OVERVIEW
  • SPECIAL TOPICS
    • Histology Automation
      • Table 13-1: Selected Histology Lab Automation
      • Table 13-2: Histology Information Technology Tools
    • Advanced Analysis Solutions
      • Table 13-3: Selected Advanced Histology Techniques
    • HPV Goes Core Lab
      • Table 13-4: Global HPV Test Sales Distribution by Region, 2020 (%) (North America, Europe, Asia Pacific, RoW)
      • Table 13-5: Selected HPV Test Innovations
  • MARKET ANALYSIS
    • Table 13-6: Global Histology/Cytology Sales by Type, 2020-2025 ($ millions) (Pap Tests, in situ hybridization, immunohistochemistry, traditional non-Pap stains, HPV, TOTAL; Digital Imaging, CTCs, Flow Cytometry)
    • Histology/Cytology
      • Table 13-7: Global Histology/Cytology Sales Distribution by Region, 2020 (%) (North America, Europe, Asia Pacific, RoW)
      • Table 13-8: Revenues of the Major Histology Companies, 2016-2019 ($ millions, estimated)
      • Table 13-9: Selected Vendors of Traditional Histology Stains
      • Table 13-10: Primary and Secondary Prevention of Cervical Cancer, Screening Responses by Country, 2017
    • Immunohistochemistry and In Situ Hybridization
      • Table 13-11: Selected In Situ Hybridization-based Tests
      • Table 13-12: Selected IHC Test Innovations
    • Pharmacodiagnostic Histology
      • Table 13-13: Major Pharmacodiagnostic Markers
      • Table 13-14: Selected Pharmacodiagnostic Histology Tests
    • Digital Imaging and Computational Pathology
    • COVID-19 and Digital Pathology
      • Table 13-15: Selected Digital Imaging Innovations
    • Circulating Tumor Cells
      • Table 13-16: Selected Innovations in CTC Technology
    • Flow Cytometry
  • THE COMMERCIAL OUTLOOK FOR HISTOLOGY AND CYTOLOGY TESTS

CHAPTER 14: COMPANY PROFILES: THE TOP TIER

  • ABBOTT DIAGNOSTICS
    • COVID-19
    • Point of Care
    • Core Lab
    • Hematology
    • Blood Banking
    • Coagulation
    • Infectious Diseases - Molecular
    • Diabetes
    • HIV Point of Care
    • i-STAT Business
    • Companion Testing
    • Liquid Biopsy
  • AGILENT TECHNOLOGIES
    • Dako / Pathology
    • Agilent in Genomics
    • Cytogenetic Analysis
    • Information Technology
    • Capillary Electrophoresis
    • Sequencing
    • CRISPR
    • Flow Cytometry
  • BECKMAN COULTER, INC. / DANAHER
    • COVID-19
    • Hematology
    • Hematology IT
    • Clinical Chemistry
    • Immunoassays
    • Coagulation
    • Microbiology
    • Urinalysis
    • Clinical Information Technology
    • Molecular Tissue Analysis
    • Flow Cytometry
    • A Fight for Brain Natriuretic Peptide (BNP) Assay Rights
    • Beckman Coulter Life Sciences
    • Collaborations
  • BECTON, DICKINSON AND COMPANY (BD)
    • Cytology
    • Molecular Microbiology
    • Traditional Microbiology - ID/AST
    • Blood Culture
    • Hospital Acquired Infections
    • Connectivity
    • Blood Collection
    • Mass Spectrometry
    • Flow Cytometry
    • Licensing
    • COVID-19
  • BIOMÉRIEUX INC.
    • Traditional Microbiology
    • Blood Culture
    • Immunoassays
    • Mass Spectrometry
    • Data Analysis
    • BioFire Diagnostics Business
    • Food Testing
    • Expansion
    • COVID-19
  • BIO-RAD LABORATORIES, INC
    • Quality Control
    • Blood Bank
    • Diabetes
    • Immunoassays
    • Autoimmune Testing
    • Liquid Biopsy
    • Microbiome
    • Droplet Digital PCR
    • Sequencing
    • COVID-19
  • BRUKER CORPORATION
    • Acquisitions and Collaborations
    • Microbiology
    • Molecular PCR
    • COVID-19
  • CEPHEID / DANAHER
    • COVID-19
    • GeneXpert Xpress Line
    • High Burden Expansion
    • India
    • Tuberculosis
    • Microbiology
    • POC Testing
    • Cancer
  • DANAHER CORPORATION
    • Acquisitions
    • DIASORIN S.P.A
    • Development Plan
    • Expansion
    • Immunoassays
    • Zika Testing
    • Molecular
    • Molecular Oncology
  • COVID-19
    • GRIFOLS S.A.
    • Blood Transfusion Business
    • ABO Blood Typing
    • Molecular ABO Blood Typing
    • Immunoassays
    • Coagulation
    • Market Expansion
    • COVID-19
  • HOLOGIC, INC.
    • Hologic Global Access Initiative
    • PANTHER Molecular System
    • HIV Testing
    • Sexually Transmitted Infections
    • Infectious Diseases
    • Panther Fusion
    • Cytology
  • INSTRUMENTATION LABORATORY (IL) / WERFEN
    • Expansion
    • Coagulation
    • Acute Care
    • Information Technology
  • LEICA BIOSYSTEMS/DANAHER
    • COVID-19
    • Digital Pathology
    • Stain Reagents
    • Lab Systems
    • Sample Handling
    • Circulating Tumor Cells (CTCs)
    • Artificial Intelligence
  • ORTHO CLINICAL DIAGNOSTICS (ORTHO)
    • COVID-19
    • Blood Bank
    • Core Lab / Immunoassays
    • Lab Automation
    • Connectivity
    • Expansion
  • PERKINELMER, INC. (PE)
    • Diagnostics
    • Sequencing /Genomics
    • Liquid Biopsy
    • Histology
    • Prenatal Business
    • COVID-19
    • Lab Services
    • Mass Spectrometry
  • QIAGEN
    • Tuberculosis
    • Molecular Expansion
    • Precision Medicine / Companion Diagnostics
    • Molecular Microbiology
    • Prenatal Testing
    • Next Generation Sequencing
    • Sample Prep, Informatics
    • Digital PCR
    • Bioinformatics
    • COVID-19
    • Liquid Biopsy
    • Microbiome
    • Cervical Cancer
    • Transplant Medicine
    • Forensic
    • Expansion
  • QUIDEL CORPORATION
    • COVID-19
    • The Alere Triage Business
    • Immunoassays
    • Rapid Immunoassays
    • The Solana Business
    • Molecular - Savanna
  • RADIOMETER A/S / DANAHER
    • Critical Care
    • Immunoassays
    • HemoCue
    • Transcutaneous Monitoring
  • ROCHE DIAGNOSTICS
    • Table 14-1: Selected Roche Diagnostics Product Advances in 2018
    • COVID-19
    • Hematology
    • Core Lab
    • Immunoassays
    • HIV
    • Molecular Expansion
    • Core Molecular
    • Digital PCR
    • Diabetes Care
    • Coagulation
    • cobas Liat System - POC
    • HPV
    • Blood Bank
    • Transplant Medicine
    • Cancer Companion Testing
    • Prenatal
    • Liquid Biopsy
    • IT in Anatomical Pathology
    • Information Technology
    • Consulting Program
    • Core Lab
    • Lab Automation
    • Immunoassays
    • Hematology
    • Urinalysis
    • Molecular
    • Expansion to Support Molecular Diagnostics - Fast Track Diagnostics
    • Sequencing with Artificial Intelligence
    • Zika Virus Testing
    • Acute Care - POC
    • POC Connectivity
    • Business Expansion
    • COVID-19
  • SYSMEX CORPORATION
    • Hematology
    • Coagulation
    • Urinalysis
    • Immunoassays
    • Lab Information System
    • Information Technology
    • Flow Cytometry
    • Precision Medicine / Companion Test Diagnostics
    • Liquid Biopsy
    • Exosomes
    • Oncology
    • Sysmex Inostics
    • Forging New Markets
    • COVID-19
  • THERMO FISHER SCIENTIFIC INC.
    • Immunoassays
    • Microbiology
    • Molecular Test Business
    • Next Generation Sequencing
    • qPCR
    • Gene Editing
    • Oncology Companion Diagnostics
    • Liquid Biopsy
    • Zika Virus
    • Transplant Medicine
    • Microbiome
    • Forensics
    • Mass Spectrometry
    • Collaborations
    • China
    • COVID-19
  • VENTANA MEDICAL SYSTEMS INC. / ROCHE TISSUE DIAGNOSTICS
    • Immunohistochemistry - IHC
    • Cervical Cancer Screening
    • Companion Diagnostics
    • Quality Control
    • DISCOVERY Product Line
  • WERFEN

CHAPTER 15: COMPANY PROFILES: THE SECOND TIER

  • ARKRAY
    • Dry Chemistry / Immunoassays
    • Urinalysis
    • Diabetes
    • Molecular
  • BGI GENOMICS (FORMERLY BEIJING GENOME INSTITUTE)
    • MGI Tech Co., Limited, China
    • Complete Genomics
    • Prenatal Testing
    • Test Services
    • Liquid Biopsy
    • Whole Genome Sequencing (WGS)
    • Collaborations
    • COVID-19
  • DEXCOM
  • DIAGNOSTICA STAGO S.A.S.
  • EIKEN CHEMICAL CO., LTD
    • Product News
    • COVID-19
  • EXACT SCIENCES
  • FUJIREBIO DIAGNOSTICS, INC.
    • Molecular
  • GENMARK DIAGNOSTICS
  • COVID-19
  • GUARDANT HEALTH
  • HORIBA
  • ILLUMINA
    • Sequencing
    • Advancing in the Clinical Market
    • Sequencing Data Analysis
    • Project Firefly
    • Transplant Medicine
    • Liquid Biopsy
    • Forensic Medicine
    • Prenatal Testing Business
    • Collaborations
    • China
    • COVID-19
  • LABCORP, LABORATORY CORPORATION OF AMERICA
    • LabCorp Buys Sequenom
    • Precision Medicine
    • Diagnostics Services
    • DTC Home Testing
    • Prenatal
    • Retail Services
    • Collaborations and Expansion
    • COVID-19
  • LUMINEX CORPORATION
    • Assay Development
    • VERIGENE Business
    • PCR
    • Flow Cytometry
    • Business Expansion
    • COVID-19
  • MASIMO CORPORATION
  • A. MENARINI DIAGNOSTICS
    • Menarini-Silicon Biosystems Inc. (Bologna, Italy)
    • COVID-19
  • MERIDIAN BIOSCIENCE, INC.
    • Immunoassays
    • Molecular Tests
    • Building U.S. and International Partnerships
    • China Businesses
    • COVID-19
  • MINDRAY - SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • Core Lab
    • Hematology
  • MYRIAD GENETICS, INC.
  • NIHON KOHDEN CORPORATION
  • NOVA BIOMEDICAL CORPORATION (NOVA)
  • PHILIPS (ROYAL PHILIPS)
    • Histology
    • Cancer Genomics
    • Precision Medicine
    • Precision Medicine IT
    • Patient Monitoring
    • Point of Care
    • Wearable Self Monitor
  • QUEST DIAGNOSTICS
    • Diagnostic Services
    • Oncology
    • Infectious Diseases
    • Prenatal and Women's Health
    • Retail / Consumer Health
    • Expansion
    • COVID-19
  • RANDOX LABORATORIES LTD.
    • Clinical Chemistries
    • Controls
    • Evidence Series - Multistat Biochip Analyzers
    • Molecular
    • COVID-19

CHAPTER 16: COMPANY PROFILES: BLOOD BANK SPECIALISTS

  • BLOODSOURCE (VITALANT)
  • CERUS CORPORATION
  • COVID-19
  • HAEMOKINESIS PTY LTD
  • IMMUCOR
  • MICROTYPING CONCEPTS
  • QUOTIENT LIMITED
  • COVID-19
  • RELIANCE LIFE SCIENCES

CHAPTER 17: COMPANY PROFILES: CORE LAB AND OTHER COMPANIES

  • AB SCIEX PTE LTD.
  • EKF DIAGNOSTICS HOLDINGS PLC
  • COVID-19
  • ELITECH GROUP S.A.S.
  • COVID-19
  • ERBA DIAGNOSTICS, INC.
  • MEDTEST DX
  • COVID-19
  • MICROSAIC SYSTEMS PLC
  • NOVA BIOMEDICAL
  • SCIENION AG
  • SEKISUI DIAGNOSTICS LLC
  • COVID-19
  • SHIMADZU SCIENTIFIC INSTRUMENTS
  • SNIBE CO. LTD., (SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO. LTD.)
  • COVID-19
  • TECAN GROUP
  • TOSOH BIOSCIENCE
  • TRINITY BIOTECH PLC

CHAPTER 18: COMPANY PROFILES: CTC & LIQUID BIOPSY TEST PROVIDERS

  • ANGLE, PLC
  • BIOCARTIS
  • BIOCEPT, INC.
  • COVID-19
  • BIODESIX
  • EPIC SCIENCES
  • EPIGENOMICS AG
  • FOUNDATION MEDICINE, INC.
  • GENOMIC HEALTH (EXACT SCIENCES)
  • GUARDANT HEALTH, INC.
  • LUNGLIFE AI
  • MENARINI-SILICON BIOSYSTEMS
  • COVID-19
  • MYRIAD GENETICS, INC.
  • NATERA
  • NEOGENOMICS

CHAPTER 19: COMPANY PROFILES: SPECIALISTS

  • ASCENSIA DIABETES CARE HOLDINGS AG
  • BIGFOOT BIOMEDICAL INC.
  • DEBIOTECH SA
  • COVID-19
  • DEXCOM INC.
  • GENTAG INC.
  • GLOOKO INC.
  • GLYSURE LIMITED
  • GLYTEC LLC
  • IHEALTH LABS INC.
  • INSULET CORPORATION
  • INTEGRITY APPLICATIONS INC.
  • LIFESCAN INC.
  • MEDTRONIC PLC
  • NEMAURA MEDICAL INC.
  • COVID-19
  • NIGHTSCOUT PROJECT
  • TRIVIDIA HEALTH INC.
  • VERILY LIFE SCIENCES LLC

CHAPTER 20: COMPANY PROFILES: HEMATOLOGY (CELL ANALYSIS) AND COAGULATION SPECIALISTS

  • CELLAVISION AB
  • DIAGNOSTICA STAGO, S.A.S.
  • DIAGON KFT. HUNGARY
  • HORIBA MEDICAL
  • MEDICA CORPORATION
  • MICROVISK TECHNOLOGIES
  • WEST MEDICA

CHAPTER 21: COMPANY PROFILES: HISTOPATHOLOGY SPECIALISTS

  • ADVANCED CELL DIAGNOSTICS (ACD)
  • AMOY DIAGNOSTICS CO. LTD.
  • APPLIED SPECTRAL IMAGING INC. (ASI)
  • BIOGENEX LABORATORIES, INC.
  • BIOVIEW LTD.
  • CIRCULOMICS INC.
  • DAKO A/S
  • HTG MOLECULAR DIAGNOSTICS
  • LEICA BIOSYSTEMS
  • MILLIPORESIGMA (FORMERLY EMD MILLIPORE)
  • COVID-19
  • VISIOPHARM

CHAPTER 22: COMPANY PROFILES: IMMUNOASSAY SPECIALISTS

  • BG MEDICINE, INC
  • BINDING SITE GROUP LTD. (THE)
  • COVID-19
  • BIODESIX
  • COVID-19
  • BIOHIT HEALTHCARE
  • BIOMERICA INC.
  • COVID-19
  • BIO-TECHNE CORPORATION
  • COVID-19
  • CORGENIX MEDICAL CORPORATION
  • CRITICAL DIAGNOSTICS
  • EUROBIO SCIENTIFIC
  • COVID-19
  • EUROIMMUN AG
  • HOB BIOTECH
  • COVID-19
  • IMMUNODIAGNOSTIC SYSTEMS (IDS)
  • INOVA DIAGNOSTICS, INC.
  • ONE LAMBDA, INC
  • ORGENTEC DIAGNOSTIKA
  • PROTAGEN DIAGNOSTICS
  • RESPONSE BIOMEDICAL CORP.
  • COVID-19
  • THERADIG
  • COVID-19
  • VOLITIONRX LIMITED
  • COVID-19

CHAPTER 23: INFORMATION TECHNOLOGY SPECIALISTS IN IN VITRO DIAGNOSTICS

  • ADVAITA CORP.
  • COVID-19
  • CERNER CORP.
  • DELL TECHNOLOGIES INC.
  • DESKTOP GENETICS LTD.
  • DNANEXUS INC.
  • EDICO GENOME (ILLUMINA)
  • EUFORMATICS OY
  • GENOMONCOLOGY LLC
  • GOOGLE LLC
  • HUMAN LONGEVITY INC.
  • INTEL CORPORATION
  • INTERNATIONAL BUSINESS MACHINES CORP. (IBM)
  • N-OF-ONE
  • PIERIANDX
  • RENNOVA HEALTH, INC.
  • SOPHIA GENETICS SA
  • COVID-19
  • SUNQUEST INFORMATION SYSTEMS INC.
  • COVID-19
  • WUXI NEXTCODE

CHAPTER 24: COMPANY PROFILES: MICROBIOLOGY SPECIALISTS

  • ACCELERATE DIAGNOSTICS, INC.
  • COVID-19
  • ADVANCED BIOLOGICAL LABORATORIES, S.A. (ABL)
  • COVID-19
  • ALTONA DIAGNOSTICS
  • COVID-19
  • ARCDIA INTERNATIONAL OY LTD.
  • COVID-19
  • BIOFIRE DIAGNOSTICS, LLC. (ACQUIRED BY BIOMÉRIEUX)
  • COVID-19
  • BRUKER BIOSCIENCES CORPORATION
  • COVID-19
  • COPAN ITALIA S.P.A. AND COPAN DIAGNOSTICS, INC.
  • COVID-19
  • CURETIS
  • COVID-19
  • FAST TRACK DIAGNOSTICS (ACQUIRED BY SIEMENS HEALTHINEERS)
  • FOCUS DIAGNOSTICS, INC
  • GENETIC ANALYSIS AS
  • COVID-19
  • GENEWEAVE BIOSCIENCES, INC.
  • GREINER BIO-ONE INTERNATIONAL GMBH
  • HAIN LIFESCIENCE GMBH
  • COVID-19
  • MAST GROUP
  • MOBIDIAG
  • COVID-19
  • Q-LINEA AB
  • OPGEN, INC.
  • SEEGENE, INC.
  • COVID-19
  • SPECIFIC TECHNOLOGIES
  • SYNBIOSIS LTD.
  • T2 BIOSYSTEMS
  • COVID-19

CHAPTER 25: COMPANY PROFILES: MOLECULAR TEST SPECIALISTS

  • ASURAGEN INC.
  • COVID-19
  • AUTOGENOMICS INC.
  • ENZO BIOCHEM INC.
  • COVID-19
  • EXOSOME DIAGNOSTICS, INC.
  • FLUIDIGM CORPORATION
  • COVID-19
  • GENMARK DIAGNOSTICS, INC
  • COVID-19
  • GENOME DIAGNOSTICS BV (GENDX)
  • NANOSTRING TECHNOLOGIES, INC.
  • COVID-19
  • OXFORD NANOPORE TECHNOLOGIES LTD
  • COVID-19
  • PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACBIO)
  • COVID-19
  • QUANDX INC
  • TAKARA BIO INC.
  • COVID-19
  • VELA DIAGNOSTICS
  • COVID-19

CHAPTER 26: COMPANY PROFILES: POINT OF CARE TEST SPECIALISTS

  • ABAXIS, INC.
  • ABINGDON HEALTH LTD.
  • BINX HEALTH
  • BIOMEME, INC.
  • CHEMBIO DIAGNOSTIC SYSTEMS, INC.
  • DNA ELECTRONICS LTD (DNAE)
  • ENTOPSIS
  • FIO CORPORATION
  • GENEDRIVE PLC (FORMERLY EPISTEM HOLDINGS)
  • NUGENEREX DIAGNOSTICS (HDS)
  • IMMUNOSTICS, INC.
  • INSILIXA INC.
  • LOOP MEDICAL
  • MEDMIRA, INC.
  • ORASURE TECHNOLOGIES, INC.
  • PTS DIAGNOSTICS
  • QUANTUMDX GROUP, LTD.
  • COVID-19
  • RHEONIX, INC.
  • SAMSUNG HEALTHCARE
  • VEREDUS LABORATORIES PTE LTD
  • COVID-19

CHAPTER 27: COMPANY PROFILES: PRENATAL TEST SERVICE PROVIDERS

  • AFFYMETRIX, INC.
  • BERRY GENOMICS CO. LTD.
  • COOPERGENOMICS (DIVISION OF COOPERSURGICAL)
  • EUROFINS LIFECODEXX AG
  • MYRIAD WOMEN'S HEALTH
  • GENOMA GROUP
  • INNOVATIONS EXCHANGE PTE LTD (INEX) AND IGENE DIAGNOSTICS PTE LTD
  • INVITAE
  • OXFORD GENE TECHNOLOGY
  • RAVGEN
  • REPRODUCTIVE GENETICS INNOVATIONS
  • SEQUENOM, INC.
  • YOURGENE HEALTH
  • COVID-19

CHAPTER 28: COMPANY PROFILES: QUALITY CONTROL & SAMPLE PRETREATMENT SPECIALISTS

  • 10X GENOMICS
  • AGENA BIOSCIENCE, INC.
  • BIOTYPE DIAGNOSTIC GMBH
  • COVID-19
  • DXTERITY DIAGNOSTICS INC.
  • COVID-19
  • HORIZON DISCOVERY GROUP PLC
  • INCELLDX
  • LGC SERACARE LIFE SCIENCES, INC.
  • COVID-19
  • OASIS DIAGNOSTICS CORPORATION
  • PREANALYTIX GMBH
  • PRECIPIO, INC. (FORMERLY TRANSGENOMIC)
  • QUANTERIX CORPORATION
  • COVID-19
  • STRECK INC.

CHAPTER 29: TEST SERVICE PROVIDERS

  • 23ANDME
  • AGENDIA BV
  • AMBRY GENETICS
  • ARUP LABORATORIES
  • COVID-19
  • THE BIOCOLLECTIVE
  • BIOREFERENCE LABORATORIES
  • COVID-19
  • BIOTHERANOSTICS
  • BLUEPRINT GENETICS OY
  • BOSTON HEART DIAGNOSTICS
  • CAREDX, INC.
  • CLEVELAND HEARTLAB INC.
  • EUROFINS GENOMICS
  • COVID-19
  • EXACT SCIENCES CORP.
  • GENOMIC VISION
  • HELOMICS CORPORATION
  • MAYO MEDICAL LABORATORIES
  • MDXHEALTH SA
  • OPKO DIAGNOSTICS
  • COVID-19
  • PATHWAY GENOMICS CORPORATION
  • SONIC HEALTHCARE
  • VERACYTE, INC.
  • VERMILLION INC.
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.